ijerph-logo

Journal Browser

Journal Browser

Geriatric Medicine: Public Health and Interdisciplinary Perspectives

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Aging".

Deadline for manuscript submissions: closed (24 March 2023) | Viewed by 3139

Special Issue Editor


E-Mail Website
Guest Editor
Department of Longevity and Social Medicine (Geriatrics), Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan
Interests: pathophysiological features and treatment of geriatric diseases; management of geriatric syndromes

Special Issue Information

Dear Colleagues,

With the explosive growth of the world’s total population, the percentage of those aged 65 and over (aging rate) in the total population has risen from 5.1% in 1950 to 9.3% in 2020 and is expected to further increase to 17.8% in 2060, indicating that the aging of the population will rapidly progress over the next 40 years. The aging of the population is one of the most important issues worldwide, not only in developed regions where the population has been aging so far, but also in developing regions. Geriatric syndromes including dementia, bed-ridden, frailty and sarcopenia are expected to increase in the future.

Extending healthy life expectancy is an urgent issue, and it is essential to support successful aging and productive aging from the aspects of medicine and medical care, with the goal of increasing the number of healthy elderly people with a high quality of life who can maintain their vitality and independence.  

In this Special Issue, we look forward to interdisciplinary academic discussions and interesting papers from the perspectives of basic, clinical, and social medicine that can contribute to improving the health, independence, and quality of life of the elderly. Specifically, we welcome research papers on topics including, but not limited to, the following:

  1. Elucidation of aging mechanisms;
  2. Preventive medicine by overcoming lifestyle-related diseases;
  3. Whole-person medical care based on comprehensive geriatric assessment;
  4. Development of advanced medicine such as regenerative medicine and gene therapy;
  5. Technological innovation in the medical and nursing care fields;
  6. Comprehensive community care;
  7. Health promotion for the elderly.

Prof. Dr. Fumihiro Mitsunobu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aging mechanisms
  • dementia
  • bedridden
  • frailty and sarcopenia
  • geriatric syndrome
  • lifestyle-related diseases
  • comprehensive geriatric assessment (CGA)
  • information and communication technology (ICT)
  • artificial intelligence (AI)
  • robotics

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 1034 KiB  
Article
Polypharmacy and the Change of Self-Rated Health in Community-Dwelling Older Adults
by Muhammad Helmi Barghouth, Elke Schaeffner, Natalie Ebert, Tim Bothe, Alice Schneider and Nina Mielke
Int. J. Environ. Res. Public Health 2023, 20(5), 4159; https://doi.org/10.3390/ijerph20054159 - 25 Feb 2023
Cited by 3 | Viewed by 1431
Abstract
Polypharmacy is associated with poorer self-rated health (SRH). However, whether polypharmacy has an impact on the SRH progression is unknown. This study investigates the association of polypharmacy with SRH change in 1428 participants of the Berlin Initiative Study aged 70 years and older [...] Read more.
Polypharmacy is associated with poorer self-rated health (SRH). However, whether polypharmacy has an impact on the SRH progression is unknown. This study investigates the association of polypharmacy with SRH change in 1428 participants of the Berlin Initiative Study aged 70 years and older over four years. Polypharmacy was defined as the intake of ≥5 medications. Descriptive statistics of SRH-change categories stratified by polypharmacy status were reported. The association of polypharmacy with being in SRH change categories was assessed using multinomial regression analysis. At baseline, mean age was 79.1 (6.1) years, 54.0% were females, and prevalence of polypharmacy was 47.1%. Participants with polypharmacy were older and had more comorbidities compared to those without polypharmacy. Over four years, five SRH-change categories were identified. After covariate adjustment, individuals with polypharmacy had higher odds of being in the stable moderate category (OR 3.55; 95% CI [2.43–5.20]), stable low category (OR 3.32; 95% CI [1.65–6.70]), decline category (OR 1.87; 95% CI [1.34–2.62]), and improvement category (OR 2.01; [1.33–3.05]) compared to being in the stable high category independent of the number of comorbidities. Reducing polypharmacy could be an impactful strategy to foster favorable SRH progression in old age. Full article
(This article belongs to the Special Issue Geriatric Medicine: Public Health and Interdisciplinary Perspectives)
Show Figures

Figure 1

8 pages, 593 KiB  
Article
Association between Serum Uric Acid Levels and Bone Mineral Density in Taiwanese Elderly Population
by Pei-Ting Chung, Hsiao-Chi Ma, Sin-Yi Huang, Hsin-Ning Lien, Kuan-Hsun Ho, Hsin-Yin Hsu, Lee-Ching Hwang, Meng-Ting Tsou, Hsin-Hui Lin and Hsin-Lung Chan
Int. J. Environ. Res. Public Health 2023, 20(4), 3448; https://doi.org/10.3390/ijerph20043448 - 16 Feb 2023
Viewed by 1437
Abstract
Osteoporosis is a progressive metabolic bone disorder characterised by a decline in bone mineral density (BMD). Some previous studies have reported a controversial relationship between uric acid and osteoporosis. This cross-sectional study aimed to assess the association between serum uric acid levels and [...] Read more.
Osteoporosis is a progressive metabolic bone disorder characterised by a decline in bone mineral density (BMD). Some previous studies have reported a controversial relationship between uric acid and osteoporosis. This cross-sectional study aimed to assess the association between serum uric acid levels and BMD in older adults from Taiwan. Data from participants aged ≥ 60 years were collected from 2008 to 2018. Furthermore, the participants were classified based on uric acid level quartiles. Regression models were used to assess the association between uric acid levels and bone health, including BMD values and risk of at least osteopenia. Crude and adjusted models of potential confounders, including age, sex and body mass index (BMI), were used. Compared with the first quartile of uric acid levels, the odds ratios for osteoporosis decreased in the higher uric acid level groups after adjustment for age, sex and BMI. The boxplot analysis showed that BMD values were higher in the groups with higher uric acid levels; moreover, the results of the multivariable linear regression model showed a consistent pattern. Notably, uric acid levels were positively correlated with BMD values. Higher uric acid levels in the elderly population might decrease the risk of at least osteopenia. As opposed to the anti-hyperuricemic policy for younger adults with a relatively lower risk of osteoporosis, BMD evaluation and urate-lowering therapy, goal adjustments should be considered for older adults with lower uric acid levels. Full article
(This article belongs to the Special Issue Geriatric Medicine: Public Health and Interdisciplinary Perspectives)
Show Figures

Figure 1

Back to TopTop